Skip to main content

Table 7 Independent factors associated with the recurrence of HCC after DAA treatment in the late phase (more than 1 year after DAA treatment completion) according to Cox proportional hazard model analysis

From: AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy

 

Hazard ratio

95% CI

p-value

Post-treatment eGFR (mL/min/1.73 m2)

0.98

0.96–0.99

0.032

  1. Data are expressed as means ± standard deviation
  2. ALT alanine aminotransferase; AST aspartate aminotransferase; AFP α-fetoprotein; eGFR estimated glomerular filtration rate; FIB-4 fibrosis-4; APRI AST to platelet ratio index; SVR sustained viral response; BCLC Barcelona Clinic Liver Cancer; CI confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us